XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (6,706,744) $ (4,659,581)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discount 1,569,003 455,003
Stock based compensation 598,694 1,232,527
Stock issuance pursuant to services agreement 100,000
Change in fair value of redemption liability 980,245
Increase (decrease) in:    
Prepaid expenses and other current assets (165,281) 99,078
Accounts payable (558,837) 440,231
Accrued interest 7,237 117,844
Due to founder (200,000)
Accrued expenses (138,352) 256,084
Net cash used in operating activities (5,494,280) (1,078,569)
Net cash provided by (used in) investing activities
Cash flows from financing activities:    
Exercise of stock options 24,389
Purchase of treasury stock, at cost (62,147)
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs 13,645,643
Payment of deferred offering costs (521,294) (106,202)
Proceeds from related party convertible notes 1,038,014
Net cash provided by financing activities 13,086,591 931,812
Net increase (decrease) in cash 7,592,311 (146,757)
Cash, beginning of period 4,356 191,852
Cash, end of period 7,596,667 45,095
Conversion of related party convertible notes:    
Related party convertible notes principal converted to common stock upon initial public offering 3,734,446
Related party convertible notes accrued interest converted to common stock upon initial public offering 186,858
Redemption liability converted to common stock upon initial public offering 980,233
Unpaid deferred offering costs 259,723
Accrued interest rollover to new notes payable $ 37,342